Integrated Filing — IndAS



General information about company
Scrip Code 506401
NSE Symbol DEEPAKNTR
MSEI Symbol NOTLISTED
ISIN INE288B01029
Name of company Deepak Nitrite Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Single segment
Start date and time of board meeting 28-May-2025   14:10:00
End date and time of board meeting 28-May-2025   16:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2015-02-13
Indicate Company website link for updated RPT policy of the Company https://www.godeepak.com/wp-content/uploads/2025/02/DNL_Policy-on-Materiality-of-Related-Party-Transaction.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There are no default on loans and Debt securities for the quarter ended 31st march 2025



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 6544700000 25264700000
Other income 189600000 1491900000
Total income 6734300000 26756600000
2 Expenses
(a) Cost of materials consumed 3802600000 14606600000
(b) Purchases of stock-in-trade 1700000 1700000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -31700000 -538100000
(d) Employee benefit expense 704400000 2750500000
(e) Finance costs 10200000 37800000
(f) Depreciation, depletion and amortisation expense 253500000 998700000
(f) Other Expenses
1 Power & fuel expenses 555100000 2293700000
2 Other expenses 735100000 3230300000
Total other expenses 1290200000 5524000000
Total expenses 6030900000 23381200000
3 Total profit before exceptional items and tax 703400000 3375400000
4 Exceptional items 0 0
5 Total profit before tax 703400000 3375400000
6 Tax expense
7 Current tax 189000000 623800000
8 Deferred tax -24300000 -12700000
9 Total tax expenses 164700000 611100000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 538700000 2764300000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 538700000 2764300000
17 Other comprehensive income net of taxes -8700000 -22000000
18 Total Comprehensive Income for the period 530000000 2742300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 272800000 272800000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.95 20.27
Diluted earnings (loss) per share from continuing operations 3.95 20.27
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.95 20.27
Diluted earnings (loss) per share from continuing and discontinued operations 3.95 20.27
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 8954100000
Capital work-in-progress 1704200000
Investment property 0
Goodwill 0
Other intangible assets 25500000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 12838600000
Trade receivables, non-current 0
Loans, non-current 13500000
Other non-current financial assets 74800000
Total non-current financial assets 12926900000
Deferred tax assets (net) 0
Other non-current assets 107600000
Total non-current assets 23718300000
2 Current assets
Inventories 4523400000
Current financial asset
Current investments 885900000
Trade receivables, current 6129300000
Cash and cash equivalents 60900000
Bank balance other than cash and cash equivalents 19700000
Loans, current 102400000
Other current financial assets 104400000
Total current financial assets 7302600000
Current tax assets (net) 0
Other current assets 630400000
Total current assets 12456400000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 36174700000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 272800000
Other equity 30992000000
Total equity attributable to owners of parent 31264800000
Non controlling interest
Total equity 31264800000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 293700000
Total non-current financial liabilities 293700000
Provisions, non-current 322300000
Deferred tax liabilities (net) 503000000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 1119000000
Current liabilities
Current financial liabilities
Borrowings, current 188700000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 495100000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 2464200000
Total Trade payable 2959300000
Other current financial liabilities 349200000
Total current financial liabilities 3497200000
Other current liabilities 107100000
Provisions, current 166800000
Current tax liabilities (Net) 19800000
Deferred government grants, Current 0
Total current liabilities 3790900000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 4909900000
Total equity and liabilites 36174700000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans -14000000 -32500000
2 Equity Instruments through Other Comprehensive Income (FVOCI) 2600000 3000000
Total Amount of items that will not be reclassified to profit and loss -11400000 -29500000
2 Income tax relating to items that will not be reclassified to profit or loss -2700000 -7500000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -8700000 -22000000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 3375400000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 37800000
Adjustments for decrease (increase) in inventories -732400000
Adjustments for decrease (increase) in trade receivables, current -45800000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 304600000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 570900000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 4400000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 998700000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 62200000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 7100000
Adjustments for dividend income 980000000
Adjustments for interest income 80000000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -213100000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -132500000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -198100000
Net cash flows from (used in) operations 3177300000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 636500000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 2540800000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 4286500000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities -228200000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 170500000
Purchase of property, plant and equipment 2099500000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 6500000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 139000000
Cash receipts from repayment of advances and loans made to other parties 1749800000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 980000000
Interest received 77700000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities -3325300000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 188600000
Repayments of borrowings 0
Payments of lease liabilities 11600000
Dividends paid 1022900000
Interest paid 37900000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 100000
Net cash flows from (used in) financing activities -883700000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -1668200000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -1668200000
Cash and cash equivalents cash flow statement at beginning of period 1729100000
Cash and cash equivalents cash flow statement at end of period 60900000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells LLP Yes 31-Jul-2027


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Deepak Nitrite Limited Deepak Fertilisers & Petrochemicals Corporation Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services Approved 413100000 -6900000 -17500000
2 Deepak Nitrite Limited Deepak Fertilisers & Petrochemicals Corporation Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Sale of goods or services Approved 29500000 -6900000 -17500000
3 Deepak Nitrite Limited Deepak Novochem Technologies Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Sale of goods or services Approved 158100000 43800000 127300000
4 Deepak Nitrite Limited Deepak Novochem Technologies Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services Approved 500000 43800000 127300000
5 Deepak Nitrite Limited Deepak Fertilisers & Petrochemicals Corporation Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Receiving of services / Reimbursement of Expenses Approved 800000 -6900000 -17500000
6 Deepak Nitrite Limited Deepak Foundation Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Receiving of services / Reimbursement of Expenses Approved 400000 0 0
7 Deepak Nitrite Limited Deepak Medical Foundation Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Receiving of services / Reimbursement of Expenses Approved 1400000 0 0
8 Deepak Nitrite Limited Deepak Cybit Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Receiving of services / Reimbursement of Expenses Approved 5200000 0 -700000
9 Deepak Nitrite Limited Arvind Envisol Limited Entity over which Independent Director or his relatives are able to exercise significant Influence or control Purchase of goods or services Approved 20800000 7900000 -20900000
10 Deepak Nitrite Limited Performance Chemiserve Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services Approved 38800000 6000000 2000000
11 Deepak Nitrite Limited Smt. Ila D. Mehta Relative of KMP Any other transaction Receiving of services / Reimbursement of Expenses Approved 2100000 0 0
12 Deepak Nitrite Limited Shri Deepak C. Mehta Key Management Personnel Remuneration Approved 45500000 0 0
13 Deepak Nitrite Limited Shri Maulik.D. Mehta Key Management Personnel Remuneration Approved 26400000 0 -7800000
14 Deepak Nitrite Limited Shri Sanjay B Upadhyay Key Management Personnel Remuneration Approval of Audit Committee of Listed entity is not required 30800000 0 -9500000
15 Deepak Nitrite Limited Shri Somsekhar A. Nanda Key Management Personnel Remuneration Approval of Audit Committee of Listed entity is not required 11200000 0 -2300000
16 Deepak Nitrite Limited Shri Girish Satarkar Key Management Personnel Remuneration Approval of Audit Committee of Listed entity is not required 12600000 0 -2500000
17 Deepak Nitrite Limited Shri Arvind Bajpai Key Management Personnel Remuneration Approval of Audit Committee of Listed entity is not required 6300000 0 -1300000
18 Deepak Nitrite Limited Hyspec Chemicals Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Sale of goods or services Approved 100000 0 0
19 Deepak Nitrite Limited Deepak Novochem Technologies Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Rendering of Services / Reimbursement of Expenses Approved 600000 43800000 127300000
20 DEEPAK PHENOLICS LIMITED Deepak Cybit Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services Approval of Audit Committee of Listed entity is not required 2500000 0 -200000
21 DEEPAK PHENOLICS LIMITED Deepak Foundation Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services Approval of Audit Committee of Listed entity is not required 300000 0 -100000
22 DEEPAK PHENOLICS LIMITED Sara Consultants A partnership firm in which a non-executive director of listed entity/its subsidiary is a partner Purchase of goods or services Approval of Audit Committee of Listed entity is not required 1800000 0 -1000000
23 DEEPAK PHENOLICS LIMITED Smt. Ila D Mehta Relative of KMP Purchase of goods or services Approval of Audit Committee of Listed entity is not required 1300000 0 0
24 DEEPAK PHENOLICS LIMITED Shri Deepak C Mehta Key Management Personnel of Subsidiary Remuneration Approval of Audit Committee of Listed entity is not required 60000000 -120000000 -180000000
25 DEEPAK PHENOLICS LIMITED Shri Meghav D Mehta Key Management Personnel of Subsidiary Remuneration Approval of Audit Committee of Listed entity is not required 300000 0 -500000
26 DEEPAK PHENOLICS LIMITED Shri Kishor Jhalaria Key Management Personnel of Subsidiary Remuneration Approval of Audit Committee of Listed entity is not required 19000000 0 -6300000
27 DEEPAK PHENOLICS LIMITED Shri Ajay Jajoo Key Management Personnel of Subsidiary Remuneration Approval of Audit Committee of Listed entity is not required 11300000 0 -2800000
28 DEEPAK PHENOLICS LIMITED Shri Chirag Shukla Key Management Personnel of Subsidiary Remuneration Approval of Audit Committee of Listed entity is not required 2900000 0 -700000
29 Deepak Chem Tech Limited Deepak Cybit Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services Approved 2700000 -100000 -300000
30 Deepak Chem Tech Limited Deepak Foundation Entities over which key managerial personnel or their relatives are able to exercise significant Influence Purchase of goods or services approved 0 -200000 0
31 Deepak Chem Tech Limited Hyspec Chemicals Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Rendering of Services / Reimbursement of Expenses Approved 0 1300000 0
32 Deepak Chem Tech Limited Hyspec Chemicals Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Sale of goods or services Approved 6900000 1300000 0
33 Deepak Chem Tech Limited Deepak Fertilisers & Petrochemicals Corporation Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Receiving of services / Reimbursement of Expenses Approved 600000 0 0
34 Deepak Chem Tech Limited Deepak Fertilisers & Petrochemicals Corporation Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Security Deposit Paid Approved 600000 0 0
35 Deepak Chem Tech Limited Deepak Fertilisers & Petrochemicals Corporation Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Refund of Security Deposit received Approved 300000 0 0
36 Deepak Chem Tech Limited Shri Meghav D Mehta Key Management Personnel of Subsidiary Remuneration Approved 26500000 0 0
37 Deepak Advanced Materials Limited (formerly known as OXOC Chemicals Limited) Deepak Medical Foundation Entities over which key managerial personnel or their relatives are able to exercise significant Influence Any other transaction Receiving of services / Reimbursement of Expenses Approved 0 0 0
38 Deepak PMC Limited Hyspec Chemicals Private Limited Entities over which key managerial personnel or their relatives are able to exercise significant Influence Sale of goods or services Approved 1400000 0 0
Total value of transaction during the reporting period 942600000